BioSpace News Archive

Business

CASMED Reports Preliminary Net Sales for the 2017 Fourth Quarter

U.S. FORE-SIGHT cerebral oximetry sales up 18% for the quarter with record domestic monitor placements.

January 4, 2018
·
4 min read
Drug Development

Ultragenyx Announces Update to UX007 Development Program in Long-Chain Fatty Acid Oxidation Disorder Patients

The company expects that a decision on a potential filing for approval based on Phase 2 data will be made in mid-2018.

January 4, 2018
·
7 min read
FDA

Sight Sciences Expands Surgical Portfolio With FDA Clearance of the OMNI Surgical System

In addition to the FDA approval, Sight Sciences also announced three key hires to the leadership team.

January 4, 2018
·
4 min read
Business

Kamada Announces Collaboration with a Consortium of Prominent Hospitals led by The Mount Sinai Hospital to Evaluate its Alpha-1 Antitrypsin Product for Preemption of Steroid Refractory Acute Graft-Versus-Host Disease

The study will be co-funded by Mount Sinai and Kamada.

January 4, 2018
·
7 min read
Policy

pSivida Granted Waiver by the FDA for NDA Filing Fee

The Company remains on track to file the Durasert NDA in early January.

January 4, 2018
·
4 min read
Number Of Shares and Voting Rights of Innate Pharma As at January 1, 2018

The company released its total number of shares outstanding as well as its voting rights as at January 1, 2018.

January 4, 2018
·
3 min read
Drug Development

Targovax Announces That ONCOS-102 Generates Immune Activation in Checkpoint Inhibitor Refractory Melanoma Patients

This is the first time ONCOS-102 has been used therapeutically in melanoma patients.

January 4, 2018
·
3 min read
Pharm Country

Helius Medical Technologies Announces Planned Five-for-One Reverse Stock Split

The Company’s common stock will begin trading on a split-adjusted basis on January 23, 2018 under the existing trading symbols.

January 4, 2018
·
5 min read
Biotech Bay

Bay Area’s ChemoCentryx Gets Up to $100M in New Capital Commitments

The cash will help advance avacopan through topline data from the Phase III ADVOCATE trial as well as potential registration filings in the U.S. and EU.

January 4, 2018
·
7 min read
Drug Development

Centerline Biomedical Completes Fifth Preclinical Study

This study was the most noteworthy Centerline study to date, demonstrating ability to track sensorized IOPS instruments precisely and efficiently, with enhanced 3-D visualization, without frequent exposure to cancer-causing ionizing radiation associated with current standard of care.

January 4, 2018
·
2 min read